Stephen Denaro - Anteris Technologies Independent Sec
| AMEUF Stock | USD 6.50 0.43 7.08% |
Insider
Stephen Denaro is Independent Sec of Anteris Technologies
| Phone | 61 13 0055 0310 |
| Web | https://www.anteristech.com |
Anteris Technologies Management Efficiency
The company has return on total asset (ROA) of (0.8433) % which means that it has lost $0.8433 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.5517) %, meaning that it generated substantial loss on money invested by shareholders. Anteris Technologies' management efficiency ratios could be used to measure how well Anteris Technologies manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Erik Gatenholm | Cellink AB | 34 | |
| Erica Bell | BICO Group AB | 50 | |
| Hassan Kotob | Brain Scientific | 59 | |
| Asa Hillsten | Cellink AB | 48 | |
| Niclas Emanuelsson | BICO Group AB | 52 | |
| Mikael Engblom | Cellink AB | 46 | |
| Artur Aira | BICO Group AB | 56 | |
| Kevin Winterfield | Brain Scientific | N/A | |
| Daniel Cloutier | Brain Scientific | 57 | |
| Karin Danielsson | BICO Group AB | 41 | |
| Trent Northcutt | Aurora Spine | 56 | |
| Laszlo Garamszegi | Aurora Spine | 52 | |
| Artur Aira | Cellink AB | 56 | |
| Mark Broderick | Brain Scientific | N/A | |
| Hector Martinez | Cellink AB | 38 | |
| Erica Bell | Cellink AB | 50 | |
| Niclas Emanuelsson | Cellink AB | 52 | |
| Richard Ginn | Tenon Medical | 58 | |
| Lotta Bus | BICO Group AB | 53 | |
| Erik Gatenholm | BICO Group AB | 34 | |
| Irina Nazarova | Brain Scientific | N/A | |
Management Performance
| Return On Equity | -2.55 | |||
| Return On Asset | -0.84 |
Anteris Technologies Leadership Team
Elected by the shareholders, the Anteris Technologies' board of directors comprises two types of representatives: Anteris Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Anteris. The board's role is to monitor Anteris Technologies' management team and ensure that shareholders' interests are well served. Anteris Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Anteris Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| AC FAA, Exec | ||
| Wayne Paterson, Non-Executive Independent Director | ||
| Matthew McDonnell, Chief Officer | ||
| David Denis, Chief Officer | ||
| Stephen Denaro, Independent Sec | ||
| Chris Olig, Bus Director | ||
| Danny Zanardo, Commercial International | ||
| MPH MD, Chief Board |
Anteris Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Anteris Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.55 | |||
| Return On Asset | -0.84 | |||
| Operating Margin | (5.05) % | |||
| Current Valuation | 196.49 M | |||
| Shares Outstanding | 13.9 M | |||
| Shares Owned By Insiders | 13.27 % | |||
| Shares Owned By Institutions | 28.34 % | |||
| Price To Earning | (3.20) X | |||
| Price To Book | 10.09 X | |||
| Price To Sales | 30.51 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Anteris Pink Sheet
Anteris Technologies financial ratios help investors to determine whether Anteris Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Anteris with respect to the benefits of owning Anteris Technologies security.